Evome Medical Technologies Inc.
LNDZF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $16 | $11 |
| - Cash | $1 | $1 | $0 | $1 |
| + Debt | $17 | $19 | $22 | $25 |
| Enterprise Value | $16 | $18 | $38 | $35 |
| Revenue | $10 | $11 | $12 | $16 |
| % Growth | -5% | -12.7% | -23.2% | – |
| Gross Profit | $4 | $3 | $4 | $6 |
| % Margin | 35.6% | 31.5% | 32.5% | 35.2% |
| EBITDA | $1 | -$1 | -$3 | -$13 |
| % Margin | 11.6% | -13% | -21.6% | -84.5% |
| Net Income | -$1 | -$2 | -$4 | -$16 |
| % Margin | -11.5% | -21.7% | -35.5% | -100.6% |
| EPS Diluted | 0 | 0 | 0 | -0.209 |
| % Growth | – | – | 100% | – |
| Operating Cash Flow | $2 | $3 | -$1 | $1 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | $2 | $3 | -$1 | $1 |